Artiva Biotherapeutics (ARTV) Return on Assets (2024 - 2025)
Artiva Biotherapeutics (ARTV) has disclosed Return on Assets for 2 consecutive years, with 0.6% as the latest value for Q4 2025.
- For Q4 2025, Return on Assets fell 31.0% year-over-year to 0.6%; the TTM value through Dec 2025 reached 0.6%, down 31.0%, while the annual FY2025 figure was 0.49%, 8.0% down from the prior year.
- Return on Assets hit 0.6% in Q4 2025 for Artiva Biotherapeutics, down from 0.5% in the prior quarter.
- Across five years, Return on Assets topped out at 0.22% in Q3 2024 and bottomed at 0.6% in Q4 2025.